|
Guo, Z S; Wang, L H; Eisensmith, R C et al. (1996) Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3:802-10
|
|
Kay, M A; Graham, F; Leland, F et al. (1995) Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-9
|
|
Kolodka, T M; Finegold, M; Kay, M A et al. (1993) Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somat Cell Mol Genet 19:491-7
|
|
Kay, M A; Rothenberg, S; Landen, C N et al. (1993) In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262:117-9
|
|
Li, Q; Kay, M A; Finegold, M et al. (1993) Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 4:403-9
|
|
Kay, M A; Baley, P; Rothenberg, S et al. (1992) Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A 89:89-93
|
|
Ponder, K P; Dunbar, R P; Wilson, D R et al. (1991) Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum Gene Ther 2:41-52
|
|
Ponder, K P; Gupta, S; Leland, F et al. (1991) Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 88:1217-21
|
|
Armentano, D; Thompson, A R; Darlington, G et al. (1990) Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci U S A 87:6141-5
|
|
Ledley, F D (1990) Clinical application of somatic gene therapy in inborn errors of metabolism. J Inherit Metab Dis 13:597-616
|
Showing the most recent 10 out of 11 publications
